Clinical Site

Jacksonville, Florida 32256

0 studies enrolling now · 7 studies all time

What they study most

Age-Related Macular Degeneration, Bipolar Depression, Cardiovascular Disease, Cardiovascular Diseases, Elevated Lipoprotein(a), Hypertriglyceridemia, Major Depressive Disorder, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration

Studies at this site

• A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) — Completed
• An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
• Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) — Completed
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease — Completed